Proteomics in Inherited Metabolic Disorders.
Ontology highlight
ABSTRACT: Inherited metabolic disorders (IMD) are rare medical conditions caused by genetic defects that interfere with the body's metabolism. The clinical phenotype is highly variable and can present at any age, although it more often manifests in childhood. The number of treatable IMDs has increased in recent years, making early diagnosis and a better understanding of the natural history of the disease more important than ever. In this review, we discuss the main challenges faced in applying proteomics to the study of IMDs, and the key advances achieved in this field using tandem mass spectrometry (MS/MS). This technology enables the analysis of large numbers of proteins in different body fluids (serum, plasma, urine, saliva, tears) with a single analysis of each sample, and can even be applied to
SUBMITTER: Chantada-Vazquez MDP
PROVIDER: S-EPMC9740208 | biostudies-literature | 2022 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA